A routine biomarker-based risk prediction model for metabolic syndrome in urban Han Chinese population

BMC Public Health

Chengqi Zhang¹  Fuzhong Xue⁴  Hongying Jia³  Fang Tang¹  Zhaohui Du⁴  Jing Liu⁴  Zhongshang Yuan⁴  Qicai Chen²  Wenchao Zhang⁴ 

[1] Health Management Center, Shandong Provincial QianFoShan Hospital, Jinan 250014, China;Shengli Qilfield Central Hospital, Dongying 257034, China;The Second Hospital of Shandong University, Jinan 250033, China;Department of Epidemiology and Biostatistics, School of Public Health, Shandong University, Jinan 250012, China

关键词: Risk matrix;    Predictor model;    Routine biomarkers;    Metabolic Syndrome (MetS);   

Others  :  1121583
DOI  :  10.1186/s12889-015-1424-z

 received in 2014-08-10, accepted in 2015-01-15,  发布年份 2015

【 摘 要 】

Background

Many MetS related biomarkers had been discovered, which provided the possibility for building the MetS prediction model. In this paper we aimed to develop a novel routine biomarker-based risk prediction model for MetS in urban Han Chinese population.

Methods

Exploring Factor analysis (EFA) was firstly conducted in MetS positive 13,345 males and 3,212 females respectively for extracting synthetic latent predictors (SLPs) from 11 routine biomarkers. Then, depending on the cohort with 5 years follow-up in 1,565 subjects (male 1,020 and female 545), a Cox model for predicting 5 years MetS was built by using SLPs as predictor; Area under the ROC curves (AUC) with 10 fold cross validation was used to evaluate its power. Absolute risk (AR) and relative absolute risk (RAR) were calculated to develop a risk matrix for visualization of risk assessment.

Results

Six SLPs were extracted by EFA from 11 routine health check-up biomarkers. Each of them reflected the specific pathogenesis of MetS, with inflammatory factor (IF) contributed by WBC & LC & NGC, erythrocyte parameter factor (EPF) by Hb & HCT, blood pressure factor (BPF) by SBP & DBP, lipid metabolism factor (LMF) by TG & HDL-C, obesity condition factor (OCF) by BMI, and glucose metabolism factor (GMF) by FBG with the total contribution of 81.55% and 79.65% for males and females respectively. The proposed metabolic syndrome synthetic predictor (MSP) based predict model demonstrated good performance for predicting 5 years MetS with the AUC of 0.802 (95% CI 0.776-0.826) in males and 0.902 (95% CI 0.874-0.925) in females respectively, even after 10 fold cross validation, AUC was still enough high with 0.796 (95% CI 0.770-0.821) in males and 0.897 (95% CI 0.868-0.921) in females. More importantly, the MSP based risk matrix with a series of risk warning index provided a feasible and practical tool for visualization of risk assessment in the prediction of MetS.

Conclusions

MetS could be explained by six SLPs in Chinese urban Han population. The proposed MSP based predict model demonstrated good performance for predicting 5 years MetS, and the MetS-based matrix provided a feasible and practical tool.

【 授权许可】

   
2015 Zhang et al.; licensee BioMed Central.

【 图 表 】

Figure 1.

Figure 2.

Figure 3.

【 参考文献 】

• [1]Huang PL: A comprehensive definition for metabolic syndrome. Dis Model Mech 2009, 2(5–6):231-7.
• [2]Yusuf S, Reddy S, Ounpuu S, Anand S: Global burden of cardiovascular diseases: Part II: variations in cardiovascular disease by specific ethnic groups and geographic regions and prevention strategies. Circulation 2001, 104(23):2855-64.
• [3]Xi B, He D, Hu Y, Zhou D: Prevalence of metabolic syndrome and its influencing factors among the Chinese adults: the China Health and Nutrition Survey in 2009. Prev Med 2013, 57(6):867-71.
• [4]Sattar N, McConnachie A, Shaper AG, Blauw GJ, Buckley BM, de Craen AJ, et al.: Can metabolic syndrome usefully predict cardiovascular disease and diabetes? Outcome data from two prospective studies. Lancet 2008, 371(9628):1927-35.
• [5]Arnlov J, Ingelsson E, Sundstrom J, Lind L: Impact of body mass index and the metabolic syndrome on the risk of cardiovascular disease and death in middle-aged men. Circulation 2010, 121(2):230-6.
• [6]Scott R, Donoghoe M, Watts GF, O'Brien R, Pardy C, Taskinen MR, et al.: Impact of metabolic syndrome and its components on cardiovascular disease event rates in 4900 patients with type 2 diabetes assigned to placebo in the FIELD randomised trial. Cardiovasc Diabetol 2011, 10:102. BioMed Central Full Text
• [7]Gami AS, Witt BJ, Howard DE, Erwin PJ, Gami LA, Somers VK, et al.: Metabolic syndrome and risk of incident cardiovascular events and death: a systematic review and meta-analysis of longitudinal studies. J Am Coll Cardiol 2007, 49(4):403-14.
• [8]He Y, Jiang B, Wang J, Feng K, Chang Q, Fan L, et al.: Prevalence of the metabolic syndrome and its relation to cardiovascular disease in an elderly Chinese population. J Am Coll Cardiol 2006, 47(8):1588-94.
• [9]Mottillo S, Filion KB, Genest J, Joseph L, Pilote L, Poirier P, et al.: The metabolic syndrome and cardiovascular risk a systematic review and meta-analysis. J Am Coll Cardiol 2010, 56(14):1113-32.
• [10]Singh AK, Kari JA: Metabolic syndrome and chronic kidney disease. Curr Opin Nephrol Hypertens 2013, 22(2):198-203.
• [11]Gluba A, Mikhailidis DP, Lip GY, Hannam S, Rysz J, Banach M: Metabolic syndrome and renal disease. Int J Cardiol 2013, 164(2):141-50.
• [12]Mohan V, Sandeep S, Deepa M, Gokulakrishnan K, Datta M, Deepa R: A diabetes risk score helps identify metabolic syndrome and cardiovascular risk in Indians - the Chennai Urban Rural Epidemiology Study (CURES-38). Diabetes Obes Metab 2007, 9(3):337-43.
• [13]Saaristo T, Peltonen M, Lindstrom J, Saarikoski L, Sundvall J, Eriksson JG, et al.: Cross-sectional evaluation of the Finnish Diabetes Risk Score: a tool to identify undetected type 2 diabetes, abnormal glucose tolerance and metabolic syndrome. Diab Vasc Dis Res 2005, 2(2):67-72.
• [14]Heldgaard PE, Griffin SJ: Routinely collected general practice data aids identification of people with hyperglycaemia and metabolic syndrome. Diabet Med 2006, 23(9):996-1002.
• [15]Hsiao FC, Wu CZ, Hsieh CH, He CT, Hung YJ, Pei D: Chinese metabolic syndrome risk score. South Med J 2009, 102(2):159-64.
• [16]Yang XH, Tao QS, Sun F, Cao CK, Zhan SY: Setting up a risk prediction model on metabolic syndrome among 35–74 year-olds based on the Taiwan MJ Health-checkup Database. Zhonghua Liu Xing Bing Xue Za Zhi 2013, 34(9):874-8.
• [17]Kawamoto R, Tabara Y, Kohara K, Miki T, Kusunoki T, Abe M, et al.: Hematological parameters are associated with metabolic syndrome in Japanese community-dwelling persons. Endocrine 2013, 43(2):334-41.
• [18]Lohsoonthorn V, Jiamjarasrungsi W, Williams MA: Association of Hematological Parameters with Clustered Components of Metabolic Syndrome among Professional and Office Workers in Bangkok, Thailand. Diabetes Metab Syndr 2007, 1(3):143-9.
• [19]Wu S, Lin H, Zhang C, Zhang Q, Zhang D, Zhang Y, et al.: Association between erythrocyte parameters and metabolic syndrome in urban Han Chinese: a longitudinal cohort study. BMC Public Health 2013, 13:989. BioMed Central Full Text
• [20]Chen W, Srinivasan SR, Xu J, Berenson GS: Black-white divergence in the relation of white blood cell count to metabolic syndrome in preadolescents, adolescents, and young adults: the Bogalusa Heart Study. Diabetes Care 2010, 33(11):2474-6.
• [21]Fan X, Liu EY, Freudenreich O, Park JH, Liu D, Wang J, et al.: Higher white blood cell counts are associated with an increased risk for metabolic syndrome and more severe psychopathology in non-diabetic patients with schizophrenia. Schizophr Res 2010, 118(1–3):211-7.
• [22]Lee YJ, Shin YH, Kim JK, Shim JY, Kang DR, Lee HR: Metabolic syndrome and its association with white blood cell count in children and adolescents in Korea: the 2005 Korean National Health and Nutrition Examination Survey. Nutr Metab Cardiovasc Dis 2010, 20(3):165-72.
• [23]Meng W, Zhang C, Zhang Q, Song X, Lin H, Zhang D, et al.: Association between leukocyte and metabolic syndrome in urban Han Chinese: a longitudinal cohort study. PLoS One 2012, 7(11):e49875.
• [24]Nakanishi N, Suzuki K, Tatara K: White blood cell count and clustered features of metabolic syndrome in Japanese male office workers. Occup Med (Lond) 2002, 52(4):213-8.
• [25]Oda E, Kawai R: Comparison between high-sensitivity C-reactive protein (hs-CRP) and white blood cell count (WBC) as an inflammatory component of metabolic syndrome in Japanese. Intern Med 2010, 49(2):117-24.
• [26]Oda E, Kawai R: The prevalence of metabolic syndrome and diabetes increases through the quartiles of white blood cell count in Japanese men and women. Intern Med 2009, 48(13):1127-34.
• [27]Park JT, Chang TI, Kim DK, Choi HY, Lee JE, Kim HW, et al.: Association of white blood cell count with metabolic syndrome in patients undergoing peritoneal dialysis. Metabolism 2009, 58(10):1379-85.
• [28]Sugimori H, Tomoda F, Koike T, Kinuno H, Kurosaki H, Masutani T, et al.: Blood rheology and platelet function in untreated early-stage essential hypertensives complicated with metabolic syndrome. Int J Hypertens 2012, 2012:109830.
• [29]Kim JA, Choi YS, Hong JI, Kim SH, Jung HH, Kim SM: Association of metabolic syndrome with white blood cell subtype and red blood cells. Endocr J 2006, 53(1):133-9.
• [30]Lu YH, Lu JM, Wang SY, Li CL, Liu LS, Zheng RP, et al.: Comparison of the diagnostic criteria of metabolic syndrome by International Diabetes Federation and that by Chinese Medical Association Diabetes Branch. Zhonghua Yi Xue Za Zhi 2006, 86(6):386-9.
• [31]Normann J, Mueller M, Biener M, Vafaie M, Katus HA, Giannitsis E: Effect of older age on diagnostic and prognostic performance of high-sensitivity troponin T in patients presenting to an emergency department. Am Heart J 2012, 164(5):698-705.
• [32]Perkins NJ, Schisterman EF: The inconsistency of “optimal” cutpoints obtained using two criteria based on the receiver operating characteristic curve. Am J Epidemiol 2006, 163(7):670-5.
• [33]Despres JP, Lemieux I: Abdominal obesity and metabolic syndrome. Nature 2006, 444(7121):881-7.
• [34]Sawada K, Krantz SB, Dessypris EN, Koury ST, Sawyer ST: Human colony-forming units-erythroid do not require accessory cells, but do require direct interaction with insulin-like growth factor I and/or insulin for erythroid development. J Clin Invest 1989, 83(5):1701-9.
• [35]Shoelson SE, Lee J, Goldfine AB: Inflammation and insulin resistance. J Clin Invest 2006, 116(7):1793-801.
• [36]Stonestreet BS, Goldstein M, Oh W, Widness JA: Effects of prolonged hyperinsulinemia on erythropoiesis in fetal sheep. Am J Physiol 1989, 257(5 Pt 2):R1199-204.
• [37]Reaven GM, Chen YD: Role of insulin in regulation of lipoprotein metabolism in diabetes. Diabetes Metab Rev 1988, 4(7):639-52.
• [38]Ferrannini E, Haffner SM, Mitchell BD, Stern MP: Hyperinsulinaemia: the key feature of a cardiovascular and metabolic syndrome. Diabetologia 1991, 34(6):416-22.
• [39]Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA. 2001;285(19):2486-2497.
• [40]Zinchuk VV, Pronko TP, Lis MA: Blood oxygen transport and endothelial dysfunction in patients with arterial hypertension. Clin Physiol Funct Imaging 2004, 24(4):205-11.
• [41]Kelm M, Rath J: Endothelial dysfunction in human coronary circulation: relevance of the L-arginine-NO pathway. Basic Res Cardiol 2001, 96(2):107-27.
• [42]Singel DJ, Stamler JS: Chemical physiology of blood flow regulation by red blood cells: the role of nitric oxide and S-nitrosohemoglobin. Annu Rev Physiol 2005, 67:99-145.
• [43]Wei Y, Liu G, Yang J, Zheng R, Jiang L, Bao P: The association between metabolic syndrome and vascular endothelial dysfunction in adolescents. Exp Ther Med 2013, 5(6):1663-6.
• [44]Facchini FS, Carantoni M, Jeppesen J, Reaven GM: Hematocrit and hemoglobin are independently related to insulin resistance and compensatory hyperinsulinemia in healthy, non-obese men and women. Metabolism 1998, 47(7):831-5.
• [45]Nakanishi N, Suzuki K, Tatara K: Haematocrit and risk of development of Type 2 diabetes mellitus in middle-aged Japanese men. Diabet Med 2004, 21(5):476-82.
• [46]Tamariz LJ, Young JH, Pankow JS, Yeh HC, Schmidt MI, Astor B, et al.: Blood viscosity and hematocrit as risk factors for type 2 diabetes mellitus: the atherosclerosis risk in communities (ARIC) study. Am J Epidemiol 2008, 168(10):1153-60.
• [47]Park E, Kim J. Gender- and Age-Specific Prevalence of Metabolic Syndrome Among Korean Adults: Analysis of the Fifth Korean National Health and Nutrition Examination Survey. J Cardiovasc Nurs. 2014. [Epub ahead of print]
• [48]Poehlman ET, Toth MJ, Gardner AW: Changes in energy balance and body composition at menopause: a controlled longitudinal study. Ann Intern Med 1995, 123(9):673-5.
• [49]Kannel WB, Cupples LA, Ramaswami R, Stokes JR, Kreger BE, Higgins M: Regional obesity and risk of cardiovascular disease; the Framingham Study. J Clin Epidemiol 1991, 44(2):183-90.
• [50]Rexrode KM, Carey VJ, Hennekens CH, Walters EE, Colditz GA, Stampfer MJ, et al.: Abdominal adiposity and coronary heart disease in women. JAMA 1998, 280(21):1843-8.
• [51]Crawford SL, Casey VA, Avis NE, McKinlay SM: A longitudinal study of weight and the menopause transition: results from the Massachusetts Women's Health Study. Menopause 2000, 7(2):96-104.
• [52]Poehlman ET, Toth MJ, Ades PA, Rosen CJ: Menopause-associated changes in plasma lipids, insulin-like growth factor I and blood pressure: a longitudinal study. Eur J Clin Invest 1997, 27(4):322-6.
• [53]Gierach GL, Johnson BD, Bairey MC, Kelsey SF, Bittner V, Olson MB, et al.: Hypertension, menopause, and coronary artery disease risk in the Women's Ischemia Syndrome Evaluation (WISE) Study. J Am Coll Cardiol 2006, 47(3 Suppl):S50-8.
• [54]Rosenthal T, Oparil S: Hypertension in women. J Hum Hypertens 2000, 14(10–11):691-704.
• [55]Staessen JA, Ginocchio G, Thijs L, Fagard R: Conventional and ambulatory blood pressure and menopause in a prospective population study. J Hum Hypertens 1997, 11(8):507-14.
• [56]Schubert CM, Rogers NL, Remsberg KE, Sun SS, Chumlea WC, Demerath EW, et al.: Lipids, lipoproteins, lifestyle, adiposity and fat-free mass during middle age: the Fels Longitudinal Study. Int J Obes (Lond) 2006, 30(2):251-60.